A synthetic peptide metalloproteinase inhibitor, but not Timp, prevents the breakdown of proteoglycan within articular cartilagein vitro

Author:

Andrews H. J.,Plumpton T. A.,Harper G. P.,Cawston T. E.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Toxicology,Pharmacology,Immunology

Reference20 articles.

1. R. A. D. Bunning, H. J. Richardson, A. Crawford, H. Skjodt, D. Hughes, D. B. Evans, M. Gowen, P. R. M. Dobson, B. L. Brown and R. G. G. Russell,The effect of IL1 on connective tissue metabolism and its relevance to arthritis. Agents and Actions (Suppl.)18, 131 152 (1986).

2. J. Saklatvala, L. M. C. Pilsworth, S. J. Sarsfield, J. Gavrilovic and J. K. Heath,Pig catabolin is a form of interleukin 1. Biochem. J.224, 461–466 (1984).

3. E. R. Pettipher, G. A. Higgs and B. Henderson,Interleukin 1 induces leukocyte infitration and cartilage proteoglycan degradation in the synovial joint. Proc. Natl. Acad. Sci. USA85, 8749–8753 (1986).

4. D. D. Wood, E. J. Ihrie, C. A. Dinarello and P. L. Cohen,Isolation of an interleukin-1-like factor from human joint effusions. Arth. Rheum.26, 975–983 (1983).

5. F. Di Giovine, D. Sitanayake and G. W. Duff,Radioimmunoassay (RIA) of interleukin 1 beta (IL1) in acute and chronic rheumatic diseases. Br. J. Rheumatol. (Suppl. 1)26, 34 (1987).

Cited by 48 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Recent opportunities in matrix metalloproteinase inhibitor drug design for cancer;Expert Opinion on Drug Discovery;2017-10-31

2. Selective Matrix Metalloproteinase Inhibitors for Cancer;Current Medicinal Chemistry;2009-10-01

3. A Bioinorganic Perspective on Matrix Metalloproteinase Inhibition;Current Topics in Medicinal Chemistry;2004-11-01

4. Advances in drug delivery for articular cartilage;Journal of Controlled Release;2003-01

5. Principles and Practices of Joint Disease Treatment;Diagnosis and Management of Lameness in the Horse;2003

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3